Also, lack of Zmat3 per se is not sufficient to cause lymphoma/leukaemia, confirming that its loss can only promote tumour development when p53-dependent apoptosis or cell cycle arrest (via Puma and p21 respectively) are impaired [59]. Here, ZMAT3 is linked to neoplasm.